{
    "2021-09-30": [
        [
            {
                "time": "2021-09-30",
                "original_text": "复星医药：同意以15.961亿元的对价转让复星医药出售权益",
                "features": {
                    "keywords": [
                        "复星医药",
                        "转让",
                        "亚能生物",
                        "金石医检所",
                        "股权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-30",
                "original_text": "复星医药拟转让亚能生物及金石医检所股权 预计贡献收益约14亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "亚能生物",
                        "金石医检所",
                        "股权转让",
                        "收益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-30",
                "original_text": "复星医药(02196)拟15.961亿元向康桥五期美元基金出售亚能生物29.02%股权及金石医检所100%股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "康桥五期美元基金",
                        "亚能生物",
                        "金石医检所",
                        "股权转让"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-30",
                "original_text": "复星医药(02196.HK)拟为控股子公司复星实业提供不超1亿美元担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复星实业",
                        "担保",
                        "借贷"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-30",
                "original_text": "复星医药：拟转让亚能生物及金石医检所股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "亚能生物",
                        "金石医检所",
                        "股权转让"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-30",
                "original_text": "复星医药(600196.SH)：集团拟以15.96亿元转让亚能生物29.02%股权及金石医检所100%股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "亚能生物",
                        "金石医检所",
                        "股权转让"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-30",
                "original_text": "复星医药(600196.SH)：子公司联合注射用曲妥珠单抗联合化疗(XELOX)启动II期临床研究",
                "features": {
                    "keywords": [
                        "复星医药",
                        "曲妥珠单抗",
                        "化疗",
                        "临床研究"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-30",
                "original_text": "复星医药：拟转让所持亚能生物合计29.02%股权及金石医检所100%股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "亚能生物",
                        "金石医检所",
                        "股权转让"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}